Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatm (Q35566338)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1, 2004

Language	Label	Description	Also known as
English	Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatm	scientific article published on January 1, 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatm (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatment with chemotherapy and antilineage-specific antibodies (English)

1 reference

10.1038/SJ.LEU.2403173

https://api.crossref.org/works/10.1038/SJ.LEU.2403173

24 March 2024

signal transduction

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14574330

24 March 2024

circulating tumor cell

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14574330

24 March 2024

1 reference

10.1038/SJ.LEU.2403173

https://api.crossref.org/works/10.1038/SJ.LEU.2403173

24 March 2024

author name string

Y. Gazitt

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14574330

24 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14574330

24 March 2024

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

full work available at URL

https://www.nature.com/articles/2403173.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14574330

24 March 2024

https://www.nature.com/articles/2403173.pdf

Portable Document Format

1 reference

10.1038/SJ.LEU.2403173

https://api.crossref.org/works/10.1038/SJ.LEU.2403173

24 March 2024

https://www.nature.com/articles/2403173

1 reference

10.1038/SJ.LEU.2403173

https://api.crossref.org/works/10.1038/SJ.LEU.2403173

24 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1-10

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphom

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage- and granulocyte-colony-stimulating factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphoma patients: a randomized prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Mechanisms of stem-/progenitor-cell mobilization: the anti-VLA-4 paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Adhesion molecules involved in transendothelial migration of human hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

CD44 isoforms in normal and leukemic hematopoiesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Mobilization of hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

The role of cytokines and adhesion molecules for mobilization of peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem-cell mobilization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Adhesion molecules in haemopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of alpha4 beta1 integrin expression and function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Comparison between granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the mobilization of peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Peripheral blood stem cell mobilization. A role for CXC chemokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

The human immunodeficiency virus (HIV)-type 1 coreceptor CXCR-4 (fusin) is preferentially expressed on the more immature CD34+ hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

CXCR4: chemokine receptor extraordinaire

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Hematopoietic stem cells are uniquely selective in their migratory response to chemokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Ex vivo treatment of proliferating human cord blood stem cells with stroma-derived factor-1 enhances their ability to engraft NOD/SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Synthesis and evaluation of pseudopeptide analogues of a specific CXCR4 inhibitor, T140: the insertion of an (E)-alkene dipeptide isostere into the betaII'-turn moiety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Novel transcription factors in human CD34 antigen-positive hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Differential mobilization of CD34+ cells and lymphoma cells in non-Hodgkin's lymphoma patients mobilized with different growth factors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Differential use of very late antigen-4 and -5 integrins by hematopoietic precursors and myeloma cells to adhere to transforming growth factor-beta1-treated bone marrow stroma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Significance of VLA-4-VCAM-1 interaction and CD44 for transendothelial invasion in a bone marrow metastatic myeloma model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Hyaluronan, a major non‐protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

CXCR4/CXCL12 expression and signalling in kidney cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

The role of chemokines in melanoma tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Expression and function of chemokine receptors in human multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

MMP9 potentiates pulmonary metastasis formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

The challenge of pathway and environment-mediated drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Survival of B lineage leukemic cells: signals from the bone marrow microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

The tumor microenvironment: focus on myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Molecular mechanisms of novel therapeutic approaches for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Hematologic malignancies: new developments and future treatments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Monoclonal antibody therapies in leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

CAMPATH (alemtuzumab) for the treatment of chronic lymphocytic leukemia and beyond

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Immunosuppressive toxicity of CAMPATH1H monoclonal antibody in the treatment of patients with recurrent low grade lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Rituximab: clinical development and future directions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

In vitro and in vivo purging of B lymphoma cells from stem-cell products using anti-CD20 Abs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Gemtuzumab ozogamicin: promise and challenge in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Gemtuzumab Ozogamicin (CMA-676, Mylotarg) for the treatment of CD33+ acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Interleukin 3 Improves the Ex Vivo Expansion of Primitive Human Cord Blood Progenitor Cells and Maintains the Engraftment Potential of SCID Repopulating Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

21 January 2018

Use of granulocyte colony-stimulating factor (G-CSF) for mobilizing peripheral blood stem cells: risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Mobilization of peripheral blood progenitor cells for autografting: chemotherapy and G-CSF or GM-CSF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of concurrent G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Difference between expression of adhesion molecules on CD34+ cells from bone marrow and G-CSF-stimulated peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Mobilization of hematopoietic primitive and committed progenitor cells into blood in mice by anti-vascular adhesion molecule-1 antibody alone or in combination with granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

L-selectin expression enhances clonogenesis of CD34+ cord blood progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of adhesion molecules on CD34(+) cells in peripheral blood of non-hodgkin's lymphoma patients mobilized with different growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Mobilization kinetics of CD34(+) cells in association with modulation of CD44 and CD31 expression during continuous intravenous administration of G-CSF in normal donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of VLA-4 and L-selectin expression on normal CD34+ cells during mobilization with G-CSF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Increase in circulating SDF-1 after treatment with sulfated glycans. The role of SDF-1 in mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34+ cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteolytic enzyme levels are increased during granulocyte colony-stimulating factor-induced hematopoietic stem cell mobilization in human donors but do not predict the number of mobilized stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Human CD34(+)CXCR4(-) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood stem cell transplantation in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

CD44 variant isoforms are involved in plasma cell adhesion to bone marrow stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential expression of chemokine receptors in B cell malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Metalloproteinase expression and prognosis in soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute and long-term toxicities associated with gemtuzumab ozogamicin (Mylotarg) therapy of acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403173

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403173

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35566338&oldid=2197487904"